UBS Group’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.1K Buy
2,328
+488
+27% +$3.63K ﹤0.01% 8009
2026
Q1
$5.67K Buy
1,840
+889
+93% +$2.34K ﹤0.01% 8756
2025
Q4
$3.32K Buy
951
+817
+610% +$5.53K ﹤0.01% 9052
2025
Q3
$1.2K Sell
134
-1,476
-92% -$11.1K ﹤0.01% 9404
2025
Q2
$10.1K Sell
1,610
-3,116
-66% -$24.4K ﹤0.01% 8856
2025
Q1
$38.8K Buy
4,726
+4,717
+52,411% +$46.5K ﹤0.01% 7772
2024
Q4
$103 Buy
9
+4
+80% +$59 ﹤0.01% 9647
2024
Q3
$87 Sell
5
-558
-99% -$14.6K ﹤0.01% 9176
2024
Q2
$12.7K Sell
563
-345
-38% -$10.3K ﹤0.01% 7587
2024
Q1
$46.8K Buy
908
+19
+2% +$1.05K ﹤0.01% 6540
2023
Q4
$62.7K Buy
889
+180
+25% +$12.4K ﹤0.01% 6425
2023
Q3
$52.1K Buy
709
+249
+54% +$25.8K ﹤0.01% 6268
2023
Q2
$68.7K Buy
460
+249
+118% +$34.4K ﹤0.01% 6283
2023
Q1
$11.2K Buy
211
+107
+103% +$6.43K ﹤0.01% 7525
2022
Q4
$9.53K Buy
104
+95
+1,056% +$20.6K ﹤0.01% 8637
2022
Q3
$2K Buy
+9
New +$2.25K ﹤0.01% 9760
2022
Q1
Sell
-44
Closed -$16K 10739
2021
Q4
$16K Buy
44
+28
+175% +$13.4K ﹤0.01% 8172
2021
Q3
$8K Sell
16
-2
-11% -$986 ﹤0.01% 8217
2021
Q2
$9K Buy
+18
New +$8.83K ﹤0.01% 8148

Other funds holding PIII

UBS Group's PIII Position: Q2 2026 in Review

UBS Group increased its P3 Health Partners (PIII) stake by 27% in Q2 2026, buying an estimated $3.63K and bringing the position to 2,328 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #8009.

UBS Group first reported a position in PIII in Q2 2021 and has held it in 19 quarters since. The position peaked at $68.7K in Q2 2023. 21 funds tracked by Wall St. Rank hold PIII as of Q2 2026.

  • UBS Group held 2,328 shares of P3 Health Partners worth $25.1K as of Q2 2026.
  • UBS Group bought 488 P3 Health Partners shares in Q2 2026, an estimated $3.63K.
  • P3 Health Partners made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8009 holding.
  • UBS Group first reported a position in P3 Health Partners in Q2 2021 and has held it in 19 quarters since.
  • UBS Group's P3 Health Partners position peaked at $68.7K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.